Inhibrx Biosciences, Inc. INBX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $982.03M.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s market capitalization?
- Inhibrx Biosciences, Inc. (INBX) reported market capitalization of $982.03M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s market capitalization changed year-over-year?
- Inhibrx Biosciences, Inc.'s market capitalization increased by 384.9% year-over-year, from $202.52M to $982.03M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s market capitalization?
- Over 3 years (2022 to 2025), Inhibrx Biosciences, Inc.'s market capitalization has grown at a 47.7% compound annual growth rate (CAGR), from $356.69M to $1.15B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.